Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
An update from DISA ( (SG:532) ) is now available.
DISA Limited has entered into a non-binding term sheet to acquire 50% of a rheumatism and arthritis medical company in Singapore. This acquisition includes a purchase consideration of S$5.5 million, with S$3 million to be paid in cash. The target company operates the only heartland-based integrated medical and therapy center for arthritis and rheumatism in Singapore, showing consistent revenue growth over the past five years. This strategic acquisition could enhance DISA’s operational scope by integrating specialized medical services, potentially strengthening its industry positioning and opening new market opportunities.
More about DISA
Current Market Cap: S$21.01M
See more insights into 532 stock on TipRanks’ Stock Analysis page.
